Legend:

• Concept Types
  • target (clinical findings)
  • classification term
  • pathway-based classification term
  • clinical findings
  • multiple types disease
  • single disease
  • disease type

'Sensation Disorders'  (Integration tree)

Pathogenesis (traditional nomenclature)

• Genetic disorders of glycan synthesis (traditional nomenclature)

Pathogenesis (new nomenclature)

• Genetic disorders of glycan synthesis (new nomenclature)

Genetic disorders of glycan synthesis (by systems, signs and symptoms)

• Genetic disorders of glycan synthesis (by systems, signs and symptoms)
  • Diseases
    • Nervous System Diseases
      • Neurologic Manifestations
        • Sensation Disorders
          • Hearing Disorders
            • Hearing Loss
              • ST3GAL5-CDG [SIAT9]
          • Vision Disorders
            • Blindness
              • PMM2-CDG (GDGDB) [PMM2]
                • PMM2-CDG, late-infantile and childhood ataxia-intellectual disability stage [PMM2]
                • PMM2-CDG, adult stable disability stage [PMM2]
              • ALG3-CDG (GDGDB) [ALG3]
              • DPM1-CDG (GDGDB) [DPM1]
              • ALG12-CDG (GDGDB) [ALG12]
              • POMT1/POMT2-CDG (cong. muscular dystrophy spectrum) (GDGDB) [POMT1,POMT2]
              • POMGNT1-CDG (cong. muscular dystrophy spectrum) (GDGDB) [POMGNT1]
              • Ehlers-Danlos syndrome, type VI (GDGDB) (GDGDB) [PLOD1]
              • ST3GAL5-CDG [SIAT9]
              • SRD5A3-CDG [SRD5A3]
            • Vision, Low
              • ALG3-CDG (GDGDB) [ALG3]
              • MPDU1-CDG (GDGDB) [MPDU1]
              • ALG1-CDG (GDGDB) [ALG1]
              • POMT1/POMT2-CDG (cong. muscular dystrophy spectrum) (GDGDB) [POMT1,POMT2]
              • POMGNT1-CDG (cong. muscular dystrophy spectrum) (GDGDB) [POMGNT1]
              • Fukuyama congenital muscular dystrophy (GDGDB) [FKTN]
              • B3GALTL-CDG [B3GALTL]
              • ALG11-CDG [ALG11]